ABT vs. CI: Abbott Laboratories vs. Cigna Stock Comparison
How do Abbott Laboratories (ABT) and Cigna (CI) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and Cigna (CI) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while CI is classified in Health Care Providers & Services.
| Profile Item | ABT | CI |
|---|---|---|
| Name | Abbott Laboratories | The Cigna Group |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 190.39 billion USD | 77.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | March 31, 1982 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | CI |
|---|---|---|
| Total Return (1Y) | -10.78% | 13.95% |
| Total Return (3Y, Annualized) | 7.79% | 2.65% |
| Total Return (5Y, Annualized) | -0.79% | 8.40% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | CI |
|---|---|---|
| Volatility (1Y, Annualized) | 28.48% | 26.82% |
| Beta (5Y) | 0.53 | 0.24 |
| Max Drawdown (5Y) | -39.64% | -32.10% |
| Avg. Volume (3M) | 8.74M | 1.55M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | CI |
|---|---|---|
| Sharpe Ratio (1Y) | -0.53 | 0.36 |
| Sortino Ratio (1Y) | -0.76 | 0.54 |
Profitability
ROE (TTM)
Cigna (CI) at 15.65% sits in the top ROE quartile, while Abbott Laboratories (ABT) at 9.14% is closer to the peer norm — stronger capital efficiency for CI.
ABT
Health Care Equipment & Services industry group
9.14%
- Max
- 47.61%
- Q3
- 14.36%
- ABT
- 9.14%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
CI
Health Care Equipment & Services industry group
15.65%
- Max
- 47.61%
- CI
- 15.65%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of Cigna (CI) at 2.09%, which keeps about the industry-typical share.
ABT
Health Care Equipment & Services industry group
9.75%
- Max
- 29.35%
- ABT
- 9.75%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
CI
Health Care Equipment & Services industry group
2.09%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- CI
- 2.09%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Abbott Laboratories (ABT) at 11.66% and Cigna (CI) at 3.48% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
ABT
Health Care Equipment & Services industry group
11.66%
- Max
- 35.43%
- Q3
- 14.14%
- ABT
- 11.66%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
CI
Health Care Equipment & Services industry group
3.48%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CI
- 3.48%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ABT | CI |
|---|---|---|
| ROE (TTM) | 9.14% | 15.65% |
| ROA (TTM) | 4.90% | 4.29% |
| Net Margin (TTM) | 9.75% | 2.09% |
| Operating Margin (TTM) | 11.66% | 3.48% |
| Gross Margin (TTM) | 57.17% | 9.09% |
Growth
Revenue Growth
Both Abbott Laboratories (ABT) at 5.67% and Cigna (CI) at 11.26% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Cigna (CI) at 83.00% sits in the top EPS growth quartile, while Abbott Laboratories (ABT) at -51.31% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | ABT | CI |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 11.26% |
| Revenue Growth (3Y CAGR) | 0.51% | 15.15% |
| EPS Growth (YoY) | -51.31% | 83.00% |
| EPS Growth (3Y CAGR) | -1.65% | 1.36% |
Financial Strength
Current Ratio (MRQ)
Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Cigna (CI) at 0.84 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CI.
ABT
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ABT
- 1.46
- Q1
- 1.37
- Min
- 0.30
CI
Health Care Equipment & Services industry group
0.84
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CI
- 0.84
- Min
- 0.30
Debt / Equity (MRQ)
Both Abbott Laboratories (ABT) at 0.61 and Cigna (CI) at 0.71 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
ABT
Health Care Equipment & Services industry group
0.61
- Max
- 1.88
- Q3
- 0.91
- ABT
- 0.61
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
CI
Health Care Equipment & Services industry group
0.71
- Max
- 1.88
- Q3
- 0.91
- CI
- 0.71
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | ABT | CI |
|---|---|---|
| Current Ratio (MRQ) | 1.46 | 0.84 |
| Debt / Equity (MRQ) | 0.61 | 0.71 |
| Net Debt / EBITDA | 2.37 | 1.87 |
Dividends
Dividend Yield (TTM)
Both Abbott Laboratories (ABT) at 2.22% and Cigna (CI) at 2.05% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
ABT
Health Care Equipment & Services industry group
2.22%
- ABT
- 2.22%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CI
Health Care Equipment & Services industry group
2.05%
- CI
- 2.05%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Abbott Laboratories (ABT) at 92.54% and Cigna (CI) at 27.29% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
ABT
Health Care Equipment & Services industry group
92.54%
- ABT
- 92.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CI
Health Care Equipment & Services industry group
27.29%
- CI
- 27.29%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | CI |
|---|---|---|
| Dividend Yield (TTM) | 2.22% | 2.05% |
| Dividend Payout Ratio (TTM) | 92.54% | 27.29% |
Valuation
P/E Ratio (TTM)
Cigna (CI) at 12.94 sits in the cheaper P/E ratio quartile, while Abbott Laboratories (ABT) at 41.02 is closer to its industry’s usual earnings multiple — a discount for CI, though growth and earnings durability still matter.
ABT
Health Care Equipment & Services industry group
41.02
- Max
- 80.41
- Q3
- 47.62
- ABT
- 41.02
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
CI
Health Care Equipment & Services industry group
12.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CI
- 12.94
- Min
- 4.21
P/S Ratio (TTM)
Cigna (CI) at 0.27 sits in the cheaper P/S ratio quartile while Abbott Laboratories (ABT) at 3.95 prices around its industry’s middle — CI costs less per dollar of sales, though read it alongside growth and margins.
ABT
Health Care Equipment & Services industry group
3.95
- Max
- 8.80
- Q3
- 4.32
- ABT
- 3.95
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
CI
Health Care Equipment & Services industry group
0.27
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CI
- 0.27
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and Cigna (CI) at 1.79 are valued close to their industries’ norm against book — neither stands out from peers.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 11.68
- Q3
- 6.12
- ABT
- 3.73
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
CI
Health Care Equipment & Services industry group
1.79
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- CI
- 1.79
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ABT | CI |
|---|---|---|
| P/E Ratio (TTM) | 41.02 | 12.94 |
| P/S Ratio (TTM) | 3.95 | 0.27 |
| P/B Ratio (MRQ) | 3.73 | 1.79 |
| Free Cash Flow Yield (TTM) | 3.19% | 10.59% |